Rate of Curative Surgery in Real-world Patients with Unresectable Metastatic Colorectal Cancer Treated with FOLFOXIRI ± Bevacizumab: A Western Canadian Province ExperienceTayyaba Bhatti, Shahid Ahmed, Osama Souied et al.|Journal of Gastrointestinal Cancer|2021Cited by 4
Conversion from unresectable to resectable liver metastases in real-world patients with liver-only metastatic colorectal cancer (mCRC) treated with FOLFOXIRI plus bevacizumab: The Conversion trial.Shahid Ahmed, Mike Moser, Deborah H. Anderson et al.|Journal of Clinical Oncology|2021Cited by 2